• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术切除联合CHOP化疗加利妥昔单抗治疗一名晚期肠系膜弥漫性大B细胞淋巴瘤患者。

Surgical resection combined with CHOP chemotherapy plus rituximab for a patient with advanced mesenteric diffuse large B cell lymphoma.

作者信息

Yamaguchi Tetsuya, Takahashi Hiroshi, Kagawa Ryuzaburou, Takeda Ryoji, Sakata Shingo, Nishizaki Daisuke, Takamatsu Teruyuki, Iwasa Yoko

机构信息

Department of Surgery, Rakuwakai-Otowa Hospital, Yamashina-ku, Kyoto 607-8062, Japan.

出版信息

Hepatogastroenterology. 2008 May-Jun;55(84):891-4.

PMID:18705290
Abstract

Herein is described a mesenteric diffuse large B cell lymphoma (DLBCL) case with a bulky mass which had achieved a complete remission by the combination therapy of a surgical resection and the CHOP chemotherapy with rituximab. A 78 year old man was referred to the Rakuwakai-Otowa Hospital due to a left lower abdominal tumor. Abdominal CT and MRI showed a bowel-like mass in the left lower abdominal cavity. Abdominal US revealed lymph node swellings at the paraaortic region. By the gastro-duodenoscopy, DLBCL of non-Hodgkin's lymphoma was proven at the 2nd portion of the duodenum. On laparotomy, a mass of 8x8cm in size was found at the mesenterium of the ileum, which directly invaded the ileum and the sigmoid mesocolon. A partial resection of the ileum and the sigmoid colon was performed. After the operation, it was determined to be Stage IV DLBCL and the chemotherapy based on the R-CHOP regimen was performed. The regimen was repeated to the 6th course. During the chemotherapy, he was confirmed to have achieved a complete remission. The present case is a rare case in which a Stage IV mesenteric DLBCL with extensive bulky masses had a favorable prognosis. Stage IV mesenteric DLBCLs with extensive bulky masses are thought to be the indication for the combination therapy of surgical resection and multiagent chemotherapy with rituximab.

摘要

本文描述了一例肠系膜弥漫性大B细胞淋巴瘤(DLBCL)病例,该病例有巨大肿块,通过手术切除联合含利妥昔单抗的CHOP化疗实现了完全缓解。一名78岁男性因左下腹肿瘤被转诊至乐和会音羽医院。腹部CT和MRI显示左下腹有肠样肿块。腹部超声显示腹主动脉旁区域淋巴结肿大。通过胃十二指肠镜检查,在十二指肠第二部证实为非霍奇金淋巴瘤的DLBCL。剖腹手术时,在回肠系膜发现一个大小为8×8cm的肿块,该肿块直接侵犯回肠和乙状结肠系膜。对回肠和乙状结肠进行了部分切除。术后,确定为IV期DLBCL,并进行了基于R-CHOP方案的化疗。该方案重复至第6疗程。化疗期间,确认其已实现完全缓解。本病例是罕见的IV期肠系膜DLBCL伴广泛巨大肿块且预后良好的病例。IV期肠系膜DLBCL伴广泛巨大肿块被认为是手术切除联合含利妥昔单抗的多药化疗的适应证。

相似文献

1
Surgical resection combined with CHOP chemotherapy plus rituximab for a patient with advanced mesenteric diffuse large B cell lymphoma.手术切除联合CHOP化疗加利妥昔单抗治疗一名晚期肠系膜弥漫性大B细胞淋巴瘤患者。
Hepatogastroenterology. 2008 May-Jun;55(84):891-4.
2
Successfully-treated mesenteric non-Hodgkin's lymphoma involving hepatic mass--a case report.成功治疗累及肝脏肿块的肠系膜非霍奇金淋巴瘤——病例报告
Gan To Kagaku Ryoho. 2007 May;34(5):783-7.
3
Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.在不列颠哥伦比亚省,采用环磷酰胺、阿霉素、长春新碱、强的松联合利妥昔单抗疗法显著改善了弥漫性大B细胞淋巴瘤的治疗效果。
J Clin Oncol. 2005 Aug 1;23(22):5027-33. doi: 10.1200/JCO.2005.09.137. Epub 2005 Jun 13.
4
[Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].中国R-CHOP方案与CHOP方案治疗初治弥漫大B细胞淋巴瘤的比较——一项多中心随机试验
Ai Zheng. 2005 Dec;24(12):1421-6.
5
[Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].利妥昔单抗联合CHOP方案与单纯CHOP方案治疗初治弥漫性大B细胞淋巴瘤患者的比较
Ai Zheng. 2005 Dec;24(12):1498-502.
6
[Efficacy of CHOP+/-Rituximab-like therapy plus radiation therapy for patients with diffuse large B-cell lymphoma stage I].CHOP±利妥昔单抗样疗法联合放射治疗对Ⅰ期弥漫性大B细胞淋巴瘤患者的疗效
Gan To Kagaku Ryoho. 2010 May;37(5):853-7.
7
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.在标准化疗基础上加用利妥昔单抗可提高弥漫性大B细胞淋巴瘤生发中心B细胞样和非生发中心B细胞样亚型的生存率。
J Clin Oncol. 2008 Oct 1;26(28):4587-94. doi: 10.1200/JCO.2007.15.9277. Epub 2008 Jul 28.
8
[A case of pulmonary intravascular lymphoma treated with CHOP chemotherapy plus rituximab].[1例采用CHOP化疗联合利妥昔单抗治疗的肺血管内大B细胞淋巴瘤]
Gan To Kagaku Ryoho. 2005 Apr;32(4):553-6.
9
Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.环磷酰胺、阿霉素、长春新碱、泼尼松和利妥昔单抗治疗人类免疫缺陷病毒相关弥漫性大B细胞淋巴瘤患者的安全性和有效性:一项II期试验的结果
Br J Haematol. 2008 Feb;140(4):411-9. doi: 10.1111/j.1365-2141.2007.06943.x. Epub 2007 Dec 19.
10
Rituximab and chemotherapy in diffuse large B-cell lymphoma.利妥昔单抗与化疗治疗弥漫性大B细胞淋巴瘤
Expert Rev Anticancer Ther. 2009 Jun;9(6):719-26. doi: 10.1586/era.09.30.

引用本文的文献

1
Diffuse large B cell lymphoma of the mesentery: an unusual presentation and review of the literature.肠系膜弥漫性大B细胞淋巴瘤:一种不寻常的表现及文献综述
J Gastrointest Cancer. 2009;40(3-4):79-82. doi: 10.1007/s12029-009-9114-7.